Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ke Tang

Showing results (451-460 of 665) with videos related to

Pageof 67
Sort By:
Journal of Cardiovascular Pharmacology|May 9, 2018
ApoA-1 Mimetic Peptide ELK-2A2K2E Decreases Inflammatory Factor Levels Through the ABCA1-JAK2-STAT3-TTP Axis in THP-1-Derived MacrophagesJia-Lin Wang, Duo Gong, Xin-Yan Hu, et al.
Journal of Molecular Cell Biology|February 27, 2018
TGFβ signaling hyperactivation-induced tumorigenicity during the derivation of neural progenitors from mouse ESCsXianfa Yang, Ran Wang, Xiongjun Wang, et al.
European Journal of Medicinal Chemistry|February 20, 2026
Discovery of 3-benzyloxy-6-arylpyridazine derivatives as novel multi-target agents toward Parkinson's disease therapyYichun Shi, Shiqin Cong, Qing Song, et al.
European Journal of Medicinal Chemistry|December 9, 2025
Benzylpiperidine-pyridazin-3(2H)-one derivatives as potential multifunctional agents against Alzheimer's diseaseYichun Shi, Heng Zhang, Shiqin Cong, et al.
Critical Reviews in Food Science and Nutrition|June 11, 2014
New perspectives on dietary-derived treatments and food safety-antinomy in a new eraSi-Yuan Pan, Si-Hua Gao, Rui-Chao Lin, et al.
Journal of Clinical Microbiology|April 24, 2015
Mixed Infections and Rifampin Heteroresistance among Mycobacterium tuberculosis Clinical IsolatesChao Zheng, Song Li, Zhongyue Luo, et al.
Expert Opinion on Biological Therapy|December 16, 2021
A randomized, double-blind, parallel-group phase I study comparing the pharmacokinetics, safety, and immunogenicity of LY01008, a candidate bevacizumab biosimilar, with its reference product Avastin® in healthy Chinese male subjectsRenpeng Zhou, Jingjing Yang, Yueyue Liu, et al.
Pain Physician|May 24, 2017
The Analgesic Effects of Celecoxib on the Formalin-induced Short- and Long-term Inflammatory PainYa-Qun Zhao, Hai-Yan Wang, Jun-Bin Yin, et al.
Journal of Cancer|January 29, 2016
Genome-wide Analysis of Epstein-Barr Virus (EBV) Integration and Strain in C666-1 and Raji CellsKai Xiao, Zhengyuan Yu, Xiayu Li, et al.
Clinical Immunology (Orlando, Fla.)|November 12, 2013
Th17 cell plays a role in the pathogenesis of Hashimoto's thyroiditis in patientsDapeng Li, Wenqian Cai, Runxia Gu, et al.
Pageof 67

Showing results (451-460 of 665) with videos related to

Sort By:
Pageof 67
Journal of Cardiovascular Pharmacology|May 9, 2018
ApoA-1 Mimetic Peptide ELK-2A2K2E Decreases Inflammatory Factor Levels Through the ABCA1-JAK2-STAT3-TTP Axis in THP-1-Derived MacrophagesJia-Lin Wang, Duo Gong, Xin-Yan Hu, et al.
Journal of Molecular Cell Biology|February 27, 2018
TGFβ signaling hyperactivation-induced tumorigenicity during the derivation of neural progenitors from mouse ESCsXianfa Yang, Ran Wang, Xiongjun Wang, et al.
European Journal of Medicinal Chemistry|February 20, 2026
Discovery of 3-benzyloxy-6-arylpyridazine derivatives as novel multi-target agents toward Parkinson's disease therapyYichun Shi, Shiqin Cong, Qing Song, et al.
European Journal of Medicinal Chemistry|December 9, 2025
Benzylpiperidine-pyridazin-3(2H)-one derivatives as potential multifunctional agents against Alzheimer's diseaseYichun Shi, Heng Zhang, Shiqin Cong, et al.
Critical Reviews in Food Science and Nutrition|June 11, 2014
New perspectives on dietary-derived treatments and food safety-antinomy in a new eraSi-Yuan Pan, Si-Hua Gao, Rui-Chao Lin, et al.
Journal of Clinical Microbiology|April 24, 2015
Mixed Infections and Rifampin Heteroresistance among Mycobacterium tuberculosis Clinical IsolatesChao Zheng, Song Li, Zhongyue Luo, et al.
Expert Opinion on Biological Therapy|December 16, 2021
A randomized, double-blind, parallel-group phase I study comparing the pharmacokinetics, safety, and immunogenicity of LY01008, a candidate bevacizumab biosimilar, with its reference product Avastin® in healthy Chinese male subjectsRenpeng Zhou, Jingjing Yang, Yueyue Liu, et al.
Pain Physician|May 24, 2017
The Analgesic Effects of Celecoxib on the Formalin-induced Short- and Long-term Inflammatory PainYa-Qun Zhao, Hai-Yan Wang, Jun-Bin Yin, et al.
Journal of Cancer|January 29, 2016
Genome-wide Analysis of Epstein-Barr Virus (EBV) Integration and Strain in C666-1 and Raji CellsKai Xiao, Zhengyuan Yu, Xiayu Li, et al.
Clinical Immunology (Orlando, Fla.)|November 12, 2013
Th17 cell plays a role in the pathogenesis of Hashimoto's thyroiditis in patientsDapeng Li, Wenqian Cai, Runxia Gu, et al.
Pageof 67